KIDRON NADAV 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Jan 8, 2024
Insider Transaction Report
Form 4
KIDRON NADAV
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-01-04+329,000→ 1,781,098 total
Holdings
- 126,000(indirect: By wholly-owned corporation)
Common Stock
Footnotes (1)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 27,417 over a three year period starting January 8, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.